The goal of the present study is to link well-defined physiologically accurate flow conditions to GCX-mediated flow-regulation of caveolae/cav-1 and activated eNOS, which are relevant to atherosclerosis prevention or onset. This evidence concerns the gene CAV1 and atherosclerosis.